Wave Life Sciences, Inc. (WVE) stock
WVENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 10/3046% below fair value
$2.77−0.07 (-2.46%)
Close on Nov 18, 2026Market cap $546.32MP/E –Yield –
Wave Life Sciences revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Wave Life Sciences's revenue for the twelve months ending Sep 30, 2026 was $70.92M. For fiscal 2025 it was $42.73M, down 60.5% from the year before. Over ten years it grew 75.7% a year on average. The highest annual figure on record is $113.31M in fiscal 2023.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $42.73M | -60.5% |
| FY2024 | Dec 31, 2024 | $108.30M | -4.4% |
| FY2023 | Dec 31, 2023 | $113.31M | +3005.1% |
| FY2022 | Dec 31, 2022 | $3.65M | -91.1% |
| FY2021 | Dec 31, 2021 | $40.96M | +104.0% |
| FY2020 | Dec 31, 2020 | $20.08M | +25.6% |
| FY2019 | Dec 31, 2019 | $15.98M | +10.9% |
| FY2018 | Dec 31, 2018 | $14.41M | +270.3% |
| FY2017 | Dec 31, 2017 | $3.89M | +256.5% |
| FY2016 | Dec 31, 2016 | $1.09M | +618.4% |
| FY2015 | Dec 31, 2015 | $152.00K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $13.16M | +72.9% |
| Q2 FY2026 | Jun 30, 2026 | $2.27M | -73.9% |
| Q1 FY2026 | Mar 31, 2026 | $38.25M | +316.9% |
| Q4 FY2025 | Dec 31, 2025 | $17.25M | -12.4% |
| Q3 FY2025 | Sep 30, 2025 | $7.61M | -39.3% |
| Q2 FY2025 | Jun 30, 2025 | $8.70M | -70.1% |
| Q1 FY2025 | Mar 31, 2025 | $9.18M | -81.4% |
| Q2 FY2024 | Jun 30, 2024 | $19.69M | -10.9% |
| Q1 FY2024 | Mar 31, 2024 | $12.54M | -3.0% |
| Q4 FY2023 | Dec 31, 2023 | $29.06M | +2245.1% |
| Q3 FY2023 | Sep 30, 2023 | $49.21M | +17168.1% |
| Q2 FY2023 | Jun 30, 2023 | $22.11M | +5794.9% |
| Q1 FY2023 | Mar 31, 2023 | $12.93M | +638.8% |
| Q4 FY2022 | Dec 31, 2022 | $1.24M | -29.8% |
| Q3 FY2022 | Sep 30, 2022 | $285.00K | -99.2% |
| Q2 FY2022 | Jun 30, 2022 | $375.00K | -86.5% |
| Q1 FY2022 | Mar 31, 2022 | $1.75M | -81.5% |
| Q4 FY2021 | Dec 31, 2021 | $1.77M | -48.8% |
| Q3 FY2021 | Sep 30, 2021 | $36.42M | +1103.3% |
| Q2 FY2021 | Jun 30, 2021 | $2.78M | -33.3% |
| Q4 FY2020 | Dec 31, 2020 | $9.44M | +293.3% |
| Q3 FY2020 | Sep 30, 2020 | $3.45M | +17.8% |
| Q2 FY2020 | Jun 30, 2020 | $3.03M | -60.3% |
| Q1 FY2020 | Mar 31, 2020 | $4.16M | +37.5% |
| Q4 FY2019 | Dec 31, 2019 | $2.40M | -33.7% |
| Q3 FY2019 | Sep 30, 2019 | $2.93M | -34.8% |
| Q2 FY2019 | Jun 30, 2019 | $7.63M | +56.3% |
| Q1 FY2019 | Mar 31, 2019 | $3.03M | +112.8% |
| Q4 FY2018 | Dec 31, 2018 | $3.62M | +229.7% |
| Q3 FY2018 | Sep 30, 2018 | $4.49M | +241.7% |
| Q2 FY2018 | Jun 30, 2018 | $4.88M | +344.8% |
| Q1 FY2018 | Mar 31, 2018 | $1.42M | +271.3% |
| Q4 FY2017 | Dec 31, 2017 | $1.10M | +62.4% |
| Q3 FY2017 | Sep 30, 2017 | $1.32M | – |
| Q2 FY2017 | Jun 30, 2017 | $1.10M | – |
| Q1 FY2017 | Mar 31, 2017 | $383.00K | – |
| Q4 FY2016 | Dec 31, 2016 | $676.00K | – |
See a number that looks wrong?